ASHP: Your Source for National Advocacy and Representation

ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s more than 43,000 members include pharmacists, student pharmacists, and pharmacy technicians. For over 70 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety.

Have you ever wondered how the ASHP Policies are created? Do you agree with getting rid of direct to consumer advertising or advocating that methadone should not be a first line pain medication?

The House of Delegates is the ultimate authority over ASHP professional policies, which express the Society's stance on important issues related to health-system pharmacy practice and medication use in society. The House of Delegates meets annually at the ASHP Summer Meetings and virtually in March and November, where it reviews policy proposals that have been approved by the Board of Directors. Most professional policies are initially drafted by ASHP councils or the executive committees of sections and forums.


To comment on the past and future work of the House of Delegates, please contact your CSHP Delegates: Molly Leber, David Goffman and Stacy Vaeth.

To learn more about ASHP, please visit their website at:

or its consumer website at:

"Who's the Medication Expert in the White Coat?"

View ASHP’s public service announcement video on the value of pharmacists. (

Practice Advancement Initiative Looks to Next Decade

As the ASHP Practice Advancement Initiative (PAI) nears its tenth year, pharmacy leaders from across the nation are helping to shape the initiative to advance pharmacy practice in ambulatory and acute care settings over the next decade. AJHP News reports that the 15-member PAI 2030 advisory panel met March 11–12 to review PAI's initial recommendations and suggest improvements and new areas of emphasis. Discussion topics included the use of healthcare analytics data to inform decision-making, emerging technologies for patient monitoring and drug delivery, how artificial intelligence may affect care delivery, and support for advanced roles for pharmacy technicians.

ASHP's Summary of Pharmacy Practice Legislation Now Available

State Legislative Issues Map:  Find out how state legislators revised your pharmacy practice act this year and when the next legislative session starts. ASHP's Provider Status/Practice Act Legislation map shows how many bills proposing to change pharmacy practice in a state were introduced this past legislative session. Click on a specific state on the map to access information about the bills' text, history, and alternate versions. The first entry for each bill's history states the final action, such as "Chaptered by Secretary of State" or "Died upon adjournment." (source: ASHP Daily Briefing 11.7.18)


ASHP Government Relations Division and its partners in the Patient Access to Pharmacists Care Coalition (PAPCC) are pushing to have provider status legislation, the Pharmacy and Medically Underserved Areas Enhancement  Act (H.R. 592), included in an upcoming hearing of the House of Representatives Energy and Commerce Committee.

The hearing will explore ways to address the opioid epidemic and presents an opportunity to highlight provider recognition of pharmacists as a policy option to curb the misuse and abuse of opioids. A favorable hearing could result in H.R. 592 being included in upcoming Medicare legislation focused on this critical issue.

Please add your voice to their efforts. Contact your representative today and ask them to request that H.R. 592 is included in the upcoming hearing.

Here's what you can do:

  1. Send an email to your representative. ASHP has provided a template that outlines the roles that pharmacists play in appropriate pain management. Please personalize it with examples of the strategies you employ to help prevent opioid abuse and misuse.
  2. Ask colleagues at your practice site to join you. Every voice counts!
  3. Brief your organization's administration and Government Relations staff on the issue.
posted 3.29.18

ASHP Provides Issue Briefs on Two Proposed CMS Rules

The Centers for Medicare & Medicaid Services (CMS) last month issued a proposed rule on Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center Payment System (ASCPS). The proposal includes cutting reimbursement rates for the 340B Drug Pricing Program, a change that ASHP intends to strongly oppose. For more information, read ASHP's issue brief on the proposal. The agency also released the 2018 Physician Fee Schedule (PFS) proposed rule, which expands the Diabetes Prevention Program to Medicare beneficiaries. For more information, read ASHP's issue brief on the PFS rule. (8/20/17)

ASHP Contributes Recommendations to Choosing Wisely Campaign
Five recommendations to facilitate optimal medication use for patients in acute and ambulatory care settings were released by ASHP on June 1 as part of the Choosing Wisely® campaign. ASHP is the first and only pharmacy organization to participate in the campaign, which is led by the ABIM Foundation and Consumer Reports to reduce waste in the healthcare system and avoid risks associated with unnecessary treatment.
(ASHP NewsLink 6.6.17)

ASHP Declares Priorities for Healthcare Reform

As federal legislators weigh options for healthcare reform, ASHP on Friday called on Congress to safeguard public health through the provision of robust coverage and outlined the organization's top priorities. Those priorities — "ASHP Principles on Healthcare Reform" — should be kept in mind by legislators as Congress works to reform healthcare, the organization said. (source: ASHP NewsLink 3.28.17) 

Advocating for Pharmacists

Wed., March 1, 2017 posted by Paul Abramowitz, PharmD, ScD (Hon), FASHP, ASHP CEO


Kasey Thompson, ASHP’s Chief Operating Officer and Senior Vice President for Policy, Planning and Communications, represented ASHP among leaders of the Patient Access to Pharmacists’ Care Coalition (PAPCC) this morning in a highly impactful fundraising breakfast for Congressman Michael C. Burgess, M.D. (R-TX). Dr. Burgess serves as the Chairman of the Subcommittee on Health of the highly influential House Energy and Commerce Committee, which is one of the House committees considering H.R. 592, the Pharmacists in Medically Underserved Areas Enhancement Act. As Chairman, Dr. Burgess plays a key role in setting the subcommittee’s agenda and ultimately determining whether legislation moves out to the full committee.

Dr. Thompson shared with Congressmen Burgess the many important clinical pharmacy services that pharmacists provide in various settings, including ambulatory clinics and throughout all care transitions. He emphasized the role that ASHP members play as direct patient care providers who optimize therapy as key members of interprofessional teams. Further, he stressed to Dr. Burgess how those vital pharmacist patient care services improve therapeutic outcomes and decrease healthcare costs.

The goal for this event was to advance efforts to pass provider status legislation in 2017. Although this is but one of many things ASHP and the PAPCC are doing to move this important legislation, we believe it was a great step in the right direction. Further, we are pleased to have had a productive discussion with such an influential member of Congress, and one who is a physician by training. Dr. Burgess did not express any opposition to our legislation and is eager to continue the discussion with members of the PAPCC about the benefits of H.R. 592. Rest assured that ASHP and the PAPCC will continue speaking with Dr. Burgess, other members of the Energy and Commerce Committee, and their colleagues in the Senate as we look to move H.R.592 and S. 109 in 2017.

2016 ASHP House of Delegates: Outcomes and Resources

submitted by Molly Billstein Leber, PharmD, BCPS, FASHP


This year was an exciting year for ASHP Policy at the House of Delegates which met at the Summer Meeting in Baltimore.  CSHP was represented by Molly Leber, Lorraine Lee and Stacy Vaeth.  The American Society of Health-System Pharmacists (ASHP), joined the physicians of the American Medical Association in a call to ban DTC ads with a policy stating “To advocate that Congress ban direct-to-consumer advertising for prescription drugs and medication-containing devices.”

Other key Policies that were passed included the following-

  • 1605 Safety of Epidural Steroid Injections
    Source: Council on Therapeutics

    To encourage healthcare providers to 1) inform patients about the significant risks and potential lack of efficacy of epidural steroid injections, 2) request their informed consent, and 3) inform patients of alternative therapies and their risks and benefits; further,
    To recommend pharmacist involvement in the medication-use process associated with epidural steroid injections when such injections are medically necessary.
  • 1608 Therapeutic Indication in Clinical Decision Support Systems
    Source: Council on Therapeutics
    To advocate that healthcare organizations optimize use of clinical decision support systems by including the appropriate indication for medications.
  • 1617 Automated Preparation and Dispensing Technology for Sterile Preparations
    Source: Council on Pharmacy Practice
    To advocate that health systems adopt automation and information technology for preparing and dispensing compounded sterile preparations when such adoption is (1) planned, implemented, and managed with pharmacists’ involvement; (2) implemented with adequate resources to promote successful development and maintenance; and (3) supported by policies and procedures that ensure the safety, effectiveness, and efficiency of the medication-use process; further,
    To educate patient safety advocacy groups and regulatory agencies on the capabilities and benefits of automation and technology for preparing and dispensing compounded sterile preparations, and to encourage them to establish expectation of adoption by health systems; further,
    To foster further research, development, and publication of best practices regarding automation and information technology for preparing and dispensing sterile preparations.
  • 1621 Timely Board of Pharmacy Licensing
    Source: Council on Public Policy

    To advocate that the National Association of Boards of Pharmacy (NABP) collaborate with boards of pharmacy to streamline the licensure process through standardization and improve the timeliness of application approval; further,

    To advocate that NABP collaborate with boards of pharmacy and third-party vendors to streamline the licensure transfer or reciprocity process; further,

    To advocate that boards of pharmacy grant licensed pharmacists in good standing temporary licensure, permitting them to engage in practice, while their application for licensure transfer or reciprocity is being processed.
  • 1622 Inclusion of Drug Product Shortages in State Price-gouging Laws
    Source: Council on Public Policy

    To urge state attorneys general to consider including shortages of lifesaving drug products within the definition of events that trigger application of state price-gouging laws.

To see all the Policies passed by the 2016 ASHP House of Delegate please visit:

If you would like to suggest a policy, please refer to the following link:


Sources of information on the deliberations of the House of Delegates that took place in June 2016  

General page for House of Delegates Information:

Polices passed by the 2016 House of Delegates:


Slideset for policies considered by the 2016 House of Delegates:

[click on third item under “Session Information]

Virtual House of Delegates FAQs:

[Next Virtual House runs from November 14-18]

NewPAI Video: The Journey to Improve Patient Care


ASHP Debuts Pharmacy Advancement Initiative

ASHP and the ASHP Foundation today announced the renaming of the former Pharmacy Practice Model Initiative (PPMI) to the Practice Advancement Initiative (PAI). The name change and debut of an updated website reflect pharmacists' expanding patient care roles in both acute and ambulatory care settings as clinical specialists and generalists. It also focuses more broadly on transitions throughout the continuum of care. The initiative's goals include clinical and healthcare team integration, advancing the roles of pharmacists as clinical specialists and generalists, leveraging pharmacy technicians, elevating the issue of pharmacist credentialing and training, and focusing on technology enhancements that can improve patient safety and outcomes. The new PAI website features tools and resources for acute and ambulatory care practitioners, including the debut of an Ambulatory Care Self-Assessment tool and "Ambulatory Care Pharmacy Progress Measures." Also, we are regenerating the Foundation Affiliate program for both PPMI and PAI grant program so that they can apply for grants to further implement PAI in their state.
Information on the grant program can be found at The grant application is here--   (source: ASHP Affiliate NewsLink 11.24.15)
ASHP Assumes Leadership Role in Campaign for Sustainable Rx Pricing
ASHP announced that it has joined the Steering Committee of the Campaign for Sustainable Rx Pricing (CSRxP). The campaign's goal is to foster a national dialogue on escalating drug prices and to find market-based solutions to address them. A project of the National Coalition on Health Care, the campaign includes the American Hospital Association, the Federation of American Hospitals, America's Health Insurance Plans, Kaiser Permanente, AARP, and many other prominent organizations concerned about the impact on patients of rapidly escalating drug prices. "By joining CSRxP, ASHP will be able to provide the perspective of our members who are on the front lines of this problem, and we will work collaboratively with our partners to ensure that medications are accessible to those who need them. Ensuring sustainable drug pricing and access are long-term efforts, and ASHP is in it for the long run," said ASHP CEO Paul W. Abramowitz.  (source: ASHP Affiliate Relations NewsLink 2.23.16)

ASHP Urges Senate Committee to Explore Policy Options to Curb Generic Drug Price Increases

A recent trend of dramatic price increases for generic drugs may make some medications inaccessible to patients and could have serious public health consequences, ASHP told members of the Senate Special Committee on Aging in a statement submitted for the record during the December 9 hearing "Sudden Price Spikes in Off-Patent Drugs: Perspectives from the Front Lines."  (Source: ASHP NewsLink 12.15.15)

Provider Coalition Rolls Out Ad Promoting Role of Pharmacists in Seniors' Care
ASHP, as part of the Patient Access to Pharmacists' Care Coalition, last week launched a media initiative to help build support for provider status legislation—the Pharmacy and Medically Underserved Areas Enhancement Act—and educate members of Congress, their staffs, and other policymakers about the roles pharmacists can play in filling the gap some patients face in accessing healthcare services in medically underserved communities.   (source: ASHP NewsLink 3.31.15)